PreHevbrio: payments to doctors
Payments that named PreHevbrio as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $119K
- Providers
- 2,686
- Transactions
- 3,674
- Average per transaction
- $32
The per-transaction average — $32 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,686 providers the average total is $44, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| VBI Vaccines (delaware) Inc. | $67,541 | 56.6% |
| VBI Vaccine (delaware) Inc. | $51,719 | 43.4% |